Search for: "Sanofi S.A."
Results 1 - 20
of 35
Sorted by Relevance
|
Sort by Date
26 Dec 2010, 9:59 pm
LLC, and Debiopharm, S.A. [read post]
18 Jan 2015, 9:06 pm
LLC; Aventis Pharma S.A.; Sanofi • Defendants: Apotex Corp.; Apotex Inc. [read post]
9 Apr 2012, 4:00 pm
In Aventis Pharma S.A. v. [read post]
30 Aug 2009, 9:43 pm
Sun Pharmaceutical Industries Ltd. et al. 3:09-cv-04333; filed August 24, 2009 in the District Court of New Jersey • Plaintiffs: Aventis Pharma S.A.; Sanofi-Aventis U.S. [read post]
9 Jan 2011, 9:09 pm
USA 1:11-cv-00018; filed January 6, 2011 in the District Court of Delaware • Plaintiffs: Aventis Pharma S.A.; Sanofi-Aventis U.S. [read post]
5 Aug 2022, 6:31 am
(which had recently been spun off from Biogen, Inc.) by Sanofi, S.A. [read post]
5 Aug 2022, 6:31 am
(which had recently been spun off from Biogen, Inc.) by Sanofi, S.A. [read post]
2 Oct 2023, 9:32 pm
Galderma S.A. [read post]
9 Jul 2023, 8:40 pm
Sanofi regarding the sufficiency of disclosure needed to satisfy the statutory enablement requirement under 35 US.C. [read post]
12 Apr 2012, 6:25 pm
Aventis Pharma S.A. et al. v. [read post]
21 Apr 2014, 2:03 pm
According to the case, Sanofi-Aventis Deutschland GmbH is the owner of the patent at issue and Aventis Pharma S.A. is the exclusive licensee of that patent. [read post]
7 Jul 2014, 11:34 am
Originally, Amphastar Pharmaceuticals, Inc. and Sanofi-Aventis S.A. battled it out in 2008 in a patent dispute over Sanofi-Aventis’s anticoagulant drug. [read post]
14 Dec 2023, 10:00 pm
August: In Nigeria, the French multinational pharmaceutical and healthcare company Sanofi S.A., filed a petition with the Corporate Affairs Commission (CAC) in 2019, alleging that the registration of Sanofi Integrated Services Limited, Sanofi Nigeria Enterprises Limited, and Sanofi Nigerian Enterprise was unlawful. [read post]
19 Jan 2023, 10:19 am
A Washington, D.C. appeals court rejected a lawsuit by Novartis AG’s Sandoz Inc that could have given it the sole right to make a generic version of Sanofi S.A. [read post]
19 Apr 2012, 10:00 pm
If there are any patent blogs you think should be highlighted by our Top 5, please comment on this post and we'll check them out. 1) CAFC Blog: Revisiting Therasense, CAFC Finds That An Inventor's Subjective Belief That Submission of Documents Was Unnecessary May Not be Sufficient to Avoid a Showing Of Intent to Deceive - This post discusses Aventis Pharma S.A. and Sanofi-Aventis U.S. [read post]
29 Oct 2009, 7:56 am
To remedy these concerns, Merck must sell its interest in Merial Limited, an animal health joint venture with Sanofi-Aventis S.A., and Schering-Plough must sell its assets related to significant drugs for nausea and vomiting in humans. [read post]
19 Apr 2012, 10:00 pm
If there are any patent blogs you think should be highlighted by our Top 5, please comment on this post and we'll check them out. 1) CAFC Blog: Revisiting Therasense, CAFC Finds That An Inventor's Subjective Belief That Submission of Documents Was Unnecessary May Not be Sufficient to Avoid a Showing Of Intent to Deceive - This post discusses Aventis Pharma S.A. and Sanofi-Aventis U.S. [read post]
16 Dec 2009, 2:51 pm
Merck's animal health business is conducted through a joint venture equally owned by Merck and Sanofi-Aventis S.A. [read post]
15 Jun 2023, 2:20 pm
., Sanofi-Aventis Deutschland GmbH v. [read post]
16 Jun 2009, 7:28 pm
The third case was Euro-Celtique, S.A. [2007] APO 13. [read post]
